10007572 J Clin Psychiatry / Document Archive

Psychiatrist.com Home    Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (Net Society Platinum [paid subscribers])

PDFs of the full text of The Primary Care Companion to The Journal of Clinical Psychiatry, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (Net Society Gold [registered users]); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (Net Society Gold [registered users])

CME Supplements from The Journal of Clinical Psychiatry (Net Society Gold [registered users])

 

The article you requested is

CME Commentary: Alzheimer’s Disease: Implications of the Updated Diagnostic and Research Criteria

J Clin Psychiatry 2011;72(9):1190-1196
10.4088/JCP.10087co1c
Copyright 2011 Physicians Postgraduate Press, Inc.

To view this item, select one of the options below.

  1. NONSUBSCRIBERS
    1. Purchase this PDF for $40
      If you are not a paid subscriber, you may purchase the PDF.
      (You'll need the free Adobe Acrobat Reader.)
    2. Subscribe
      Receive immediate full-text access to JCP. You can subscribe to JCP print + online for $166 individual.
      JCP's 75th AnniversaryCelebrate!
      Celebrate JCP's 75th Anniversary with a special online-only subscription price of $75.
  2. PAID SUBSCRIBERS
    1. Activate
      If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
    2. Sign in
      As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
  1. Did you forget your password?

Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send an email

| 54.227.67.175

Alzheimer’s disease (AD) is the most common form of disabling cognitive impairment in older people. The diagnostic criteria for AD were developed almost 30 years ago by the National Institute of Neurological and Communicative Disorders and Stroke (NINCDS) and the Alzheimer’s Disease and Related Disorders Association (ADRDA, more commonly known as the Alzheimer’s Association). The National Institute on Aging (NIA) and the Alzheimer’s Association recently released updated research and diagnostic criteria for AD. Additionally, the American Psychiatric Association (APA) is currently revising the Diagnostic and Statistical Manual of Mental Disorders (DSM), which will include updated diagnostic criteria for neurocognitive disorders including AD. In this Commentary, the experts discuss the background of the original diagnostic criteria for AD and the rationale behind revising those criteria, including reconceptualizing the AD spectrum and using biomarkers and genetics in AD diagnoses and prognoses, as well as review the proposed DSM criteria revisions and how they relate to the new NIA/Alzheimer’s criteria.